Clay Northam Wealth Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Sell
3,853
-350
-8% -$92.9K 0.92% 21
2026
Q1
$461K Buy
4,203
+355
+9% +$50.6K 0.26% 62
2025
Q4
$640K Buy
3,848
+663
+21% +$111K 0.36% 44
2025
Q3
$624K Buy
3,185
+590
+23% +$97K 0.36% 44
2025
Q2
$235K Buy
+2,595
New +$205K 0.15% 76

Other funds holding ALAB

Clay Northam Wealth Management's ALAB Position: Q2 2026 in Review

Clay Northam Wealth Management reduced its Astera Labs (ALAB) stake by 8.3% in Q2 2026, selling an estimated $92.9K and leaving 3,853 shares worth $1.86M. The position accounts for 0.92% of the portfolio, ranked #21.

Clay Northam Wealth Management first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Clay Northam Wealth Management held 3,853 shares of Astera Labs worth $1.86M as of Q2 2026.
  • Clay Northam Wealth Management sold 350 Astera Labs shares in Q2 2026, an estimated $92.9K.
  • Astera Labs made up 0.92% of Clay Northam Wealth Management's portfolio in Q2 2026, its #21 holding.
  • Clay Northam Wealth Management first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Clay Northam Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.